Global Bcr-Abl Antibody Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Bcr-Abl Antibody Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Bcr-Abl Antibody is a specific antibody used to detect and study Bcr-Abl protein.
Bcr-Abl Antibody report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Bcr-Abl Antibody market is projected to reach US$ 894.4 million in 2029, increasing from US$ 394.6 million in 2022, with the CAGR of 12.4% during the period of 2024 to 2029. Demand from Flow Cytometry and ELISA are the major drivers for the industry.
Bcr-Abl is a fusion protein produced by the fusion of Bcr (breakpoint cluster region) and Abl (Abelson) genes, which is commonly found in chronic myeloid leukemia (CML) and other tumors. The fusion protein has kinase activity and has abnormal effects on cell signaling pathways, causing cells to lose normal growth and differentiation control, thereby promoting tumor development. Bcr-Abl antibody can be used to study the expression and localization of Bcr-Abl protein and its relationship with tumor development, cell proliferation, etc., which is helpful for in-depth understanding of the function and mechanism of Bcr-Abl in tumor biology. In addition, due to the key role of Bcr-Abl in CML and other tumors, Bcr-Abl antibodies may also have potential clinical application value in cancer diagnosis, treatment and monitoring efficacy.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Bcr-Abl Antibody market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Abbexa
Biorbyt
Bio-Techne
Creative Biolabs
LifeSpan BioSciences, Inc
Abcam
RayBiotech, Inc.
Assay Genie
Sino Biological, Inc.
Cell Signaling Technology, Inc.
GeneTex
Arigo Biolaboratories Corp.
MyBiosource, Inc.
OriGene Technologies, Inc.
Segment by Type
Monoclonal Antibody
Polyclonal Antibody
Flow Cytometry
ELISA
Western Blot
Immunoprecipitation
Immunofluorescence
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Bcr-Abl Antibody market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Bcr-Abl Antibody, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Bcr-Abl Antibody industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Bcr-Abl Antibody in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Bcr-Abl Antibody introduction, etc. Bcr-Abl Antibody Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Bcr-Abl Antibody market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Bcr-Abl Antibody report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Bcr-Abl Antibody market is projected to reach US$ 894.4 million in 2029, increasing from US$ 394.6 million in 2022, with the CAGR of 12.4% during the period of 2024 to 2029. Demand from Flow Cytometry and ELISA are the major drivers for the industry.
Bcr-Abl is a fusion protein produced by the fusion of Bcr (breakpoint cluster region) and Abl (Abelson) genes, which is commonly found in chronic myeloid leukemia (CML) and other tumors. The fusion protein has kinase activity and has abnormal effects on cell signaling pathways, causing cells to lose normal growth and differentiation control, thereby promoting tumor development. Bcr-Abl antibody can be used to study the expression and localization of Bcr-Abl protein and its relationship with tumor development, cell proliferation, etc., which is helpful for in-depth understanding of the function and mechanism of Bcr-Abl in tumor biology. In addition, due to the key role of Bcr-Abl in CML and other tumors, Bcr-Abl antibodies may also have potential clinical application value in cancer diagnosis, treatment and monitoring efficacy.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Bcr-Abl Antibody market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Abbexa
Biorbyt
Bio-Techne
Creative Biolabs
LifeSpan BioSciences, Inc
Abcam
RayBiotech, Inc.
Assay Genie
Sino Biological, Inc.
Cell Signaling Technology, Inc.
GeneTex
Arigo Biolaboratories Corp.
MyBiosource, Inc.
OriGene Technologies, Inc.
Segment by Type
Monoclonal Antibody
Polyclonal Antibody
Segment by Application
Flow Cytometry
ELISA
Western Blot
Immunoprecipitation
Immunofluorescence
Others
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Bcr-Abl Antibody market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Bcr-Abl Antibody, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Bcr-Abl Antibody industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Bcr-Abl Antibody in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Bcr-Abl Antibody introduction, etc. Bcr-Abl Antibody Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Bcr-Abl Antibody market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.